Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MiNA Therapeutics
Biotech
Lilly invests in MiNA to fund trials of protein-upregulating RNA
The $15 million investment comes two months after Lilly agreed to pay $25 million upfront to work with MiNA on up to five targets.
Nick Paul Taylor
Jul 6, 2021 8:10am
Outsmarting cancer with RNA and other gene-altering therapies
Jun 28, 2021 5:00pm
Lilly, MiNA ink broad deal to upregulate proteins using RNA
May 11, 2021 6:45am
Servier, MiNA ally to upregulate neurological disorder proteins
Jan 21, 2021 8:00am
MiNA raises $30M to take small activating RNA into phase 2
Sep 10, 2020 7:05am
